Wattana Karnpaet PCLBKK:NEW 87 PEG Ratio is 0.95 as of Jul. 05, 2026, which is 67% below its 10-year median of 2.89. GuruFocus rates BKK:NEW with a GF Score™ of 87/100 and a GF Value™ of ฿97.11 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 225 Healthcare Providers & Services companies, Wattana Karnpaet PCL ranks better than 66.67% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Wattana Karnpaet PCL's PEG Ratio or its related term are showing as below:
BKK:NEW'
s PEG Ratio Range Over the Past 10 Years
Min: 0.37 Med: 2.89 Max: 413.23
Current: 0.95
During the past 13 years, Wattana Karnpaet PCL's highest PEG Ratio was 413.23. The lowest was 0.37. And the median was 2.89.
BKK:NEW's PEG Ratio is ranked better than 66.67% of 225
companies
in the Healthcare Providers & Services industry
Industry Median: 1.41
vs BKK:NEW: 0.95
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Wattana Karnpaet PCL (BKK:NEW) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Wattana Karnpaet PCL PEG Ratio Related Terms
Wattana Karnpaet PCL PEG Ratio Historical Data
* Premium members only.
The historical data trend for Wattana Karnpaet PCL's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Wattana Karnpaet PCL's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wattana Karnpaet PCL PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wattana Karnpaet PCL's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Wattana Karnpaet PCL's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Wattana Karnpaet PCL (BKK:NEW) has a PEG Ratio of 0.95 as of Jul. 05, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Wattana Karnpaet PCL and its competitors. This is 67% below median its historical median of 2.89. Over the past decade, Wattana Karnpaet PCL's PEG Ratio has ranged from 0.37 to 413.23. According to the industry distribution chart, Wattana Karnpaet PCL ranks #75 out of 225 companies in the Healthcare Providers & Services industry, placing it in the top 33.3%.
Is Wattana Karnpaet PCL's PEG Ratio too high?
Wattana Karnpaet PCL's current PEG Ratio of 0.95 is 67% below median its 10-year median of 2.89. Over the past 10 years, this metric has ranged from a low of 0.37 to a high of 413.23. The Healthcare Providers & Services industry median PEG Ratio is 1.41. Wattana Karnpaet PCL's value of 0.95 is 32.6% below this industry median. Based on the distribution chart, Wattana Karnpaet PCL ranks #75 out of 225 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Wattana Karnpaet PCL has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Wattana Karnpaet PCL's PEG Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wattana Karnpaet PCL ranks #75 out of 225 companies for PEG Ratio. This puts Wattana Karnpaet PCL in the upper half of its industry. The industry median PEG Ratio is 1.41. Wattana Karnpaet PCL's value of 0.95 is 32.6% below this benchmark. Historically, Wattana Karnpaet PCL's own PEG Ratio has ranged from 0.37 to 413.23 over the past decade. While the company's 10-year median is 2.89 vs. the industry median of 1.41, Wattana Karnpaet PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.41, based on 225 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wattana Karnpaet PCL's current PEG Ratio of 0.95 is 32.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Wattana Karnpaet PCL and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wattana Karnpaet PCL's current PEG Ratio is 0.95, which is 67% below median its own 10-year median of 2.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wattana Karnpaet PCL stock overvalued right now?
Based on GuruFocus' analysis, Wattana Karnpaet PCL (BKK:NEW) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿97.11, compared to a current price of ฿80.50 — trading 17.1% below its estimated fair value. The current PEG Ratio is 0.95, which is 67% below median its 10-year median of 2.89 and 32.6% below the Healthcare Providers & Services industry median of 1.41. Wattana Karnpaet PCL's overall GF Score™ is 87/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Wattana Karnpaet PCL (BKK:NEW), the current PEG Ratio is 0.95 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wattana Karnpaet PCL (BKK:NEW) Overvalued in 2026?
Based on GuruFocus' analysis, Wattana Karnpaet PCL stock appears to be undervalued.
The current stock price of ฿80.50 is trading 17.1% below its estimated GF Value™ of ฿97.11.
GuruFocus considers Wattana Karnpaet PCL to be Modestly Undervalued.
Key valuation signals for BKK:NEW:
PEG Ratio: 0.95 (67% below median its 10-year median of 2.89)
GF Value™: ฿97.11 vs. price of ฿80.50 (17.1% below fair value)
Industry Position: 32.6% below the Healthcare Providers & Services median (#75 of 225)
No single metric tells the full story. See the BKK:NEW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wattana Karnpaet PCL is engaged in the operation of a hospital under the name North Eastern Wattana Hospital. It has a single segment of operation, namely the hospital and medical trading business. The company earns revenue from hospital, revenue from sales of medicines, and revenue from hospital rooms, which are derived from the provision of services to various types and a large number of customers. Geographically, the company's operations are carried out in Thailand.
87GF Score
Get the complete analysis for BKK:NEW
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:NEW has been successfully added to your 
